» Articles » PMID: 38799792

Lung Cancer in the Emergency Department

Overview
Specialty Critical Care
Date 2024 May 27
PMID 38799792
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Though decreasing in incidence and mortality in the USA, lung cancer remains the deadliest of all cancers. For a significant number of patients, the emergency department (ED) provides the first pivotal step in lung cancer prevention, diagnosis, and management. As screening recommendations and treatments advance, ED providers must stay up-to-date with the latest lung cancer recommendations. The purpose of this review is to identify the many ways that emergency providers may intersect with the disease spectrum of lung cancer and provide an updated array of knowledge regarding detection, management, complications, and interdisciplinary care.

Findings: Lung cancer, encompassing 10-12% of cancer-related emergency department visits and a 66% admission rate, is the most fatal malignancy in both men and women. Most patients presenting to the ED have not seen a primary care provider or undergone screening. Ultimately, half of those with a new lung cancer diagnosis in the ED die within 1 year. Incidental findings on computed tomography are mostly benign, but emergency staff must be aware of the factors that make them high risk. Radiologic presentations range from asymptomatic nodules to diffuse metastatic lesions with predominately pulmonary symptoms, and some may present with extra-thoracic manifestations including neurologic. The short-term prognosis for ED lung cancer patients is worse than that of other malignancies. Screening offers new hope through earlier diagnosis but is underutilized which may be due to racial and socioeconomic disparities. New treatments provide optimism but lead to new complications, some long-term. Multidisciplinary care is essential, and emergency medicine is responsible for the disposition of patients to the appropriate specialists at inpatient and outpatient centers.

Conclusion: ED providers are intimately involved in all aspects of lung cancer care. Risk factor modification and referral for lung cancer screening are opportunities to further enhance patient care. In addition, with the advent of newer cancer therapies, ED providers must stay vigilant and up-to-date with all aspects of lung cancer including disparities, staging, symptoms of disease, prognosis, treatment, and therapy-related complications.

Citing Articles

Navigating Emergency Management of Cancer Patients: A Retrospective Study on First-Time, End-Stage, and Other Established Diagnoses in a High Turnover Emergency County Hospital.

Corlade-Andrei M, Iacobescu R, Popa V, Hauta A, Nedelea P, Grigorasi G Medicina (Kaunas). 2025; 61(1).

PMID: 39859115 PMC: 11767032. DOI: 10.3390/medicina61010133.


Investigating socioeconomic disparities in lung cancer diagnosis, treatment and mortality: an Italian cohort study.

Servadio M, Rosa A, Addis A, Kirchmayer U, Cozzi I, Michelozzi P BMC Public Health. 2024; 24(1):1543.

PMID: 38849792 PMC: 11161996. DOI: 10.1186/s12889-024-19041-4.


Risk Prediction of Emergency Department Visits in Patients With Lung Cancer Using Machine Learning: Retrospective Observational Study.

Lee A, Park H, Yoo A, Kim S, Sunwoo L, Yoo S JMIR Med Inform. 2023; 11:e53058.

PMID: 38055320 PMC: 10733827. DOI: 10.2196/53058.

References
1.
Gorham J, Ameye L, Berghmans T, Sculier J, Meert A . The lung cancer patient at the emergency department: a three-year retrospective study. Lung Cancer. 2013; 80(2):203-8. DOI: 10.1016/j.lungcan.2012.12.006. View

2.
Duma N, Santana-Davila R, Molina J . Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc. 2019; 94(8):1623-1640. DOI: 10.1016/j.mayocp.2019.01.013. View

3.
Suhail A, Crocker C, Das B, Payne J, Manos D . Initial presentation of lung cancer in the emergency department: a descriptive analysis. CMAJ Open. 2019; 7(1):E117-E123. PMC: 6404960. DOI: 10.9778/cmajo.20180061. View

4.
Carter B, Glisson B, Truong M, Erasmus J . Small cell lung carcinoma: staging, imaging, and treatment considerations. Radiographics. 2014; 34(6):1707-21. DOI: 10.1148/rg.346140178. View

5.
Fedewa S, Kazerooni E, Studts J, Smith R, Bandi P, Sauer A . State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States. J Natl Cancer Inst. 2020; 113(8):1044-1052. PMC: 8328984. DOI: 10.1093/jnci/djaa170. View